3 NSE Pharma Stocks Turning Bullish
Three Nifty Pharma stocks, including Aurobindo Pharma and Sun Pharma, showed bullish momentum shifts, coinciding with a top-ranked sector score of 91.0.
- Visit the stock pages: AUROPHARMA, SUNPHARMA, MANKIND
- Sector CNXPHARMA , which ranks #1 for Relative Strength (Altra Sector score of 91.0 with bullish regime.)
The Nifty Pharma sector recently captured significant attention, with a cluster of its constituents registering bullish turns in their Altra Scores within a single session. This development comes as the sector itself maintains a robust position, currently ranking first among all sectors with an Altra Sector score of 91.0, indicating a strong bullish momentum profile. Such sector-wide movements, especially when multiple stocks participate, can signal important shifts for traders and investors.
To understand these shifts, it’s helpful to define a few key terms. The Altra Score is a comprehensive momentum metric, ranging from 0 to 100, assigned to individual stocks. It's derived from the alignment of Exponential Moving Averages (EMAs) and the trend of the Relative Strength Index (RSI) across daily, weekly, and monthly timeframes; a higher score indicates more bullish momentum. The Altra Market score applies similar principles market-wide, reflecting the percentage of stocks above key EMAs and offering a read on overall market breadth. Lastly, the Altra Sector score assesses momentum at the sector level, providing a relative strength rank against other sectors in the same market.
While the broader NSE market, reflected by an Altra Market score of 60.1, indicates improving breadth with 68.0% of stocks above their 20-day EMA and a 15-day score trend of +11.3, the recent daily data showing 6 advances against 44 declines suggests a mixed underlying texture, reinforcing the advice to "be selective – favor high-quality setups." Within this nuanced market, the Nifty Pharma sector's leadership is evident, holding an Altra Sector score of 91.0 and ranking as the top sector. Despite this, its "Confirmed leader, cooling off" status with an RS RSI of 74.9 suggests a slight moderation from peak relative strength, making individual stock momentum even more critical.
AUROPHARMA
Aurobindo Pharma Ltd. (AUROPHARMA) showcased a decisive momentum shift on August 4, 2026. Its Altra Score surged from a Neutral 54.7 to a robust 85.2, signifying a transition into a Strong Bullish momentum regime. An Altra Score above 80 typically reflects a powerful, well-established upward trend across multiple timeframes. This strength is corroborated by its daily, weekly, and monthly Relative Strength Index (RSI) readings of 56.53, 67.07, and 81.8, respectively, all indicating healthy and sustained price strength. Furthermore, AUROPHARMA’s stock price is positioned above its key Exponential Moving Averages (EMAs), a classic technical sign of an uptrend. A significant bullish Weekly EMA Crossover, observed as early as November 14, 2025, laid the groundwork for this strong momentum, which continues to be reinforced by the stock's current top-down alignment—meaning its momentum signals are consistent across short, medium, and long-term views.
SUNPHARMA
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) also demonstrated a positive momentum evolution, with its Altra Score climbing from a Neutral 55.1 to a Bullish 69.6 on August 4, 2026. While not as high as AUROPHARMA's score, a 69.6 Altra Score firmly places SUNPHARMA in a bullish momentum phase, suggesting a consistent upward trend. Its daily (56.32), weekly (64.01), and monthly (65.5) RSI values reflect positive momentum, with the weekly and monthly figures indicating sustained strength over longer periods. Like AUROPHARMA, SUNPHARMA’s price is currently trading above its key EMAs, which is often interpreted as a sign of underlying buying interest. A more recent bullish Weekly EMA Crossover occurred on May 1, 2026, further supporting its current bullish posture. The stock also exhibits top-down alignment, reinforcing the cohesion of its bullish signals across different timeframes.
MANKIND
Mankind Pharma Ltd. (MANKIND) presents a more nuanced picture. It initially registered a bullish shift, with its Altra Score increasing from 45.7 to 63.1 (Neutral to Bullish) on August 3, 2026. However, momentum can be highly dynamic, and MANKIND serves as a clear illustration of this. As of today, its Altra Score stands significantly lower at 36.1, indicating a shift back into a Bearish momentum regime. While a bullish Weekly EMA Crossover was indeed observed on May 15, 2026, this past event could not sustain the momentum. The current data shows the stock now trading below its key EMAs, a stark contrast to its earlier bullish signal and often a precursor to further weakness. Furthermore, its daily RSI of 43.75, which is below the 50-level, indicates short-term selling pressure. The lack of top-down alignment further suggests a disconnect in momentum across its various timeframes, contributing to the current bearish score. This rapid reversal underscores the importance of continuous monitoring of momentum indicators.
In summary, while the Nifty Pharma sector showcases strong leadership and a high Altra Sector score, the individual stock momentum can diverge significantly. Aurobindo Pharma and Sun Pharma recently confirmed or strengthened their bullish momentum, aligning with the sector's overall strength. However, Mankind Pharma’s swift reversal from a bullish signal to a bearish standing highlights the dynamic and sometimes volatile nature of stock momentum. These varied outcomes within a leading sector underscore the value of granular, multi-timeframe momentum analysis provided by tools like the Altra Score for identifying both robust trends and potential shifts in market sentiment.
What is the Altra Score? The Altra Score is AltraOne's proprietary momentum score for individual stocks, ranging from 0 to 100. It measures EMA structure and RSI momentum across multiple timeframes. A score above 60 is Bullish, below 40 is Bearish, and 40–60 is Neutral. The score is updated every trading day after market close based on end-of-day data.
Explore the full Signal History on AltraOne to see every EMA crossover signal across your watchlist — going back 52 weeks. The weekly EMA crossover is AltraOne's highest-conviction intermediate momentum signal; the Signal History page lets you track how these have played out over time.
Altra Score is a momentum indicator reflecting EMA alignment and RSI trend across daily, weekly, and monthly timeframes. It is not investment advice. Past momentum does not guarantee future performance. Please consult a SEBI-registered advisor before making investment decisions.